Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells
Clinical trial NCT01546506 · COMPLETED
Trial details
- NCT number
- NCT01546506
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.